Analysis: Drugmakers vulnerable if health law revoked – msnbc.com
Full repeal of the law could prompt a short-term rally of 3 percent to 5 percent for drugmakers' shares as investors account for the annulment of taxes and a delay in generic competition for profitable biotechnology medicines, said Michael Meyers ...
Subscribe to LegalLaw247.Com Newsletter